cognitive cybersecurity intelligence

News and Analysis

Search

Lassa Fever Vaccine Clinical Trial Begins, Marking Key Step Forward

Clinical trials are under way for a candidate vaccine for Lassa fever at the University of Maryland School of Medicine, sponsored by NIH’s National Institute of Allergy and Infectious Diseases. The LASSARAB vaccine, using an inactivated rabies virus has already been shown to protect animals from lethal doses of Lassa virus. The disease, spread by rodents and person-to-person contact, often results in severe illness and permanent hearing loss. There are currently no specific treatments for Lassa fever.

Source: www.genengnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

How To Spot And Steer Clear Of It

A malvertising campaign named Storm-0408 impacted nearly a million devices, with users downloading malware from GitHub that gave criminals access to login details, OneDrive accounts,